TSS
VRPX

Two Sigma Securities’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History

Two Sigma Securities’s Portfolio VRPX Stock Details VRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-501
Closed -$8.7K – 3518
2024
Q3 		$8.7K Buy
+501
New +$12.4K ﹤0.01% 2618
2024
Q1 		– Sell
-47
Closed -$3.74K – 3856
2023
Q4 		$3.74K Buy
+47
New +$7.04K ﹤0.01% 2903
2023
Q3 		– Sell
-48
Closed -$12.9K – 3625
2023
Q2 		$12.9K Buy
+48
New +$9.93K ﹤0.01% 2562

Other funds holding VRPX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
VWM
Vermillion Wealth Management Rosemount, Minnesota $427M AUM 12.63% 1-Year Est. Return

Two Sigma Securities's VRPX Position: Q4 2024 in Review

Two Sigma Securities sold out of Virpax Pharmaceuticals, Inc. Common Stock (VRPX) in Q4 2024, closing a stake of 501 shares — an estimated $8.7K sold.

Two Sigma Securities first reported a position in VRPX in Q2 2023 and held it in 3 quarters. The position peaked at $12.9K in Q2 2023. 11 funds tracked by Wall St. Rank hold VRPX as of Q4 2024.

  • Two Sigma Securities reported no remaining Virpax Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Securities sold 501 Virpax Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $8.7K.
  • Two Sigma Securities first reported a position in Virpax Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • Two Sigma Securities's Virpax Pharmaceuticals, Inc. Common Stock position peaked at $12.9K in Q2 2023.
  • 11 funds tracked by Wall St. Rank held Virpax Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.